Shenzhen Third People’s Hospital

Running trials

• Not yet recruiting

  A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus Erythematosus

  NCT07760155· Phase 2· Source

• Not yet recruiting

  Clinical Study on the Effectiveness of Antibiotics Combined With Bifidobacterium Quadruple Live Tablets in Treating Cirrhosis With Spontaneous Bacterial Peritonitis and Preventing Recurrence

  NCT07686861· Phase 4· Source

• Recruiting

  Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study

  NCT07637877· Phase 2· Source

• Recruiting

  A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease)

  NCT07820644· Source

• Not yet recruiting

  Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation

  NCT07422701· Source

• Recruiting

  A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases

  NCT07143045· Source

• Recruiting

  Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents

  NCT07307235· Phase 4· Source

• Recruiting

  A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

  NCT07282353· Phase 3· Source

• Recruiting

  A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

  NCT07209761· Phase 3· Source

• Recruiting

  A PAN-USR TB Multi-Center Trial

  NCT06905522· Phase 3· Source

• Not yet recruiting

  Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer

  NCT07007286· Source

• Not yet recruiting

  A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

  NCT06926647· Source

• Recruiting

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· Phase 3· Source

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Source

• Recruiting

  Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy

  NCT06563947· Phase 2· Source

• Recruiting

  Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

  NCT05939167· Phase 1/2· Source

• Recruiting

  Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

  NCT05905172· Phase 3· Source

• Enrolling by invitation

  A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B

  NCT06707922· Source

• Active, not recruiting

  Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients

  NCT04538911· Phase 1· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Source

• Active, not recruiting

  Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

  NCT06524427· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hepatitis B4 recruiting
• Liver and biliary tract cancer3 recruiting
• Liver cirrhosis3 recruiting
• Fatty liver disease (MASLD/MASH)2 recruiting
• HIV2 recruiting
• Tuberculosis2 recruiting
• Lung cancer1 recruiting
• Lupus (SLE)1 recruiting
• Primary biliary cholangitis1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above

  NCT05899179· Phase 3· Source

• Completed

  Phase II Clinical Clical of the Pure Protein Derivatives of BCG

  NCT06975774· Phase 1· Source

• Completed

  ICVAX as a HIV Therapeutic DNA Vaccine

  NCT06253533· Phase 1· Source

• Completed

  Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.

  NCT05115942· Phase 3· Source

• Completed

  HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

  NCT04694495· Source

• Completed

  A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B

  NCT04846491· Phase 3· Source

• Completed

  Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

  NCT03547908· Phase 3· Source

• Completed

  Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma

  NCT07204262· Source

Trial sites

• Shenzhen Third People's Hospital17 trials
• The Third People's Hospital of Shenzhen11 trials
• Third People's Hospital Of Shenzhen1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Tuberculosis69 works · 5 trials
• Hepatitis B14 works · 7 trials